These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11649542)

  • 1. Evaluating risk when antihypertensive medications are abruptly discontinued in research subjects.
    Houston MC
    IRB; 1984; 6(1):9-11. PubMed ID: 11649542
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of placebos in randomized clinical trials.
    Levine RJ; Schafer A
    IRB; 1985; 7(2):1-6. PubMed ID: 11649622
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-free research in schizophrenia: an overview of the controversy.
    Appelbaum PS
    IRB; 1996; 18(1):1-5. PubMed ID: 11660192
    [No Abstract]   [Full Text] [Related]  

  • 4. Sugaring the pill.
    Cohen P
    New Sci; 1996 Jan; 149(2014):26-9. PubMed ID: 11660088
    [No Abstract]   [Full Text] [Related]  

  • 5. Deception and the placebo effect in biomedical research.
    Connelly RJ
    IRB; 1987; 9(4):5-7. PubMed ID: 11649948
    [No Abstract]   [Full Text] [Related]  

  • 6. Dilemmas in the use of active control groups in clinical research.
    Makuch RW; Johnson MF
    IRB; 1989; 11(1):1-5. PubMed ID: 11659084
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives of protocol reviewers.
    Moline ML; Aisen MW
    J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical dilemmas with studies in less-developed countries: AIDS research trials.
    Barry M
    IRB; 1991; 13(4):8-9. PubMed ID: 11651483
    [No Abstract]   [Full Text] [Related]  

  • 9. Enormous ethical challenges.
    Kane JM
    J Calif Alliance Ment Ill; 1994; 5(1):28-9. PubMed ID: 11653312
    [No Abstract]   [Full Text] [Related]  

  • 10. Should patients be 'tortured' in the name of progress?
    Sargant W
    Times (Lond); 1975 Aug; ():10. PubMed ID: 11648822
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo controls are not good science.
    Weijer C; Appelbaum P
    IRB; 1996; 18(5):8-10. PubMed ID: 11654741
    [No Abstract]   [Full Text] [Related]  

  • 12. The placebo is not dead: three historical vignettes.
    Cohen PJ
    IRB; 1998; 20(2-3):6-8. PubMed ID: 11656914
    [No Abstract]   [Full Text] [Related]  

  • 13. The controlled clinical trial: medicine's most powerful tool.
    Spodick DH
    Humanist; 1982; 42(3):12-21, 48. PubMed ID: 11650674
    [No Abstract]   [Full Text] [Related]  

  • 14. Placebo: pro and con.
    Lapierre YD; Weijer C
    NCEHR Commun; 1997-1998 Winter-Spring; 8(2):11-5. PubMed ID: 11660612
    [No Abstract]   [Full Text] [Related]  

  • 15. Some ethical issues associated with HIV vaccine trials.
    Novick A
    AIDS Public Policy J; 1988; 3(3):46-8. PubMed ID: 11650102
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical AIDS research that evaluates cost effectiveness in the developing world.
    Christakis NA; Lynn LA; Castelo A
    IRB; 1991; 13(4):6-8. PubMed ID: 11651482
    [No Abstract]   [Full Text] [Related]  

  • 17. Placebo-controlled trials and the logic of clinical purpose.
    Freedman B
    IRB; 1990; 12(6):1-6. PubMed ID: 11651265
    [No Abstract]   [Full Text] [Related]  

  • 18. The battle over babies: international research in perinatal HIV transmission.
    Crigger BJ
    IRB; 1998; 20(4):13-5. PubMed ID: 11657087
    [No Abstract]   [Full Text] [Related]  

  • 19. Endings of clinical research protocols: distinguishing therapy from research.
    Grinnell F
    IRB; 1990; 12(4):1-3. PubMed ID: 11651260
    [No Abstract]   [Full Text] [Related]  

  • 20. Approving high risk, rejecting low risk: the case of two cases.
    Shannon TA; Ockene IS; Levine RJ
    IRB; 1985; 7(1):6-8. PubMed ID: 11649618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.